CB-2782

N/A

Report date: 2023/11/21 10:36:07
NME

Base Information

Drug NameCB-2782
Drug Alias Nameanti-C3 proteaseAnti-complement Factor 3 (C3) pegylated CB 2782CB-2782-PEGCB-2782CB 2782-PEG +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement C3 inhibitors
TargetsComplement C3
Therapy Area/IndicationsGeographic AtrophyRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCatalyst Bioscience
China Registration ClassN/A

Develop Information

Active CompaniesMosaic BiosciencesCatalyst BioscienceCatalyst Biosciences Inc +[4] 
Inactive CompaniesN/A
Active IndicationsGeographic AtrophyRetinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A